10 Unsettling Truths About Artificial Intelligence (AI) & Automation in Federal Contracts
Artificial Intelligence (AI) & Automation in Federal ContractsAlright, so here we are, smack dab in a world where the U.S. federal government, the slow-moving behemoth of bureaucracy, is suddenly obsessed with algorithms, machine learning, and automation. It’s weird. And kind of thrilling. Contracts that used to be awarded over months of coffee-fueled handshakes and file […]
Humana’s Deep Ties with Federal Health Contracts (and the Tangled Web Others Want In On)
There’s something almost eerie about walking into a military base clinic and seeing a name like Humana glowing on the signboard, like a giant corporate monolith peering into a tightly run federal machine. And yet, here we are in 2025, still watching Humana Inc. operate as a fixture in U.S. federal healthcare, shaping programs from TRICARE to […]
Top 10 Legal Considerations in Federal Procurement You Can’t Afford to Ignore
Federal procurement is a labyrinth of opportunities—and legal intricacies. For agencies and contractors alike, knowing the legal landscape is just as vital as understanding the bidding process. This post dives deep into the most critical legal considerations in federal procurement, offering clarity on how to manage disputes and litigation when things go awry. Why Legal […]
Leidos Is Blazing a Trail Through Federal Tech
There’s something oddly poetic about a defense contractor winning billions in government work while the rest of the tech world rides the rollercoaster of venture capital drama and AI-powered existential crises. Leidos Holdings Inc. isn’t just thriving—it’s dominating, expanding, and yes, reshaping the very narrative of federal digital modernization. If you’ve been paying attention to the […]
McKesson’s Federal Supply Chain Playbook: Small Business Growth Tips
When it comes to supplying America’s healthcare system, McKesson Corporation plays in the big leagues. As one of the largest pharmaceutical and medical supply distributors in the U.S., McKesson holds massive contracts with the federal government—helping deliver everything from PPE and vaccines to essential medications. But how does a company manage such huge responsibilities, and what can smaller businesses learn […]
Pfizer’s $60M Reality Check: A Chaotic but Crucial Lesson in Compliance
In January 2025, pharmaceutical giant Pfizer made headlines when it agreed to pay nearly $60 million to resolve allegations involving its acquisition, Biohaven Pharmaceutical Holding Company Ltd. The U.S. Department of Justice alleged that Biohaven caused the submission of false claims to federal healthcare programs—including Medicare—by offering kickbacks to providers in exchange for prescribing its migraine treatment, Nurtec ODT. While Pfizer did not admit wrongdoing, the case […]
How Public-Private Partnerships Are Reshaping Federal Projects Under Trump
The Rise (and Chaos) of Public-Private Partnerships in Trump’s Infrastructure Plan Public-Private Partnerships (PPPs). The future of infrastructure? Or a bureaucratic maze designed to confuse even the most seasoned federal contractor? Well, under Trump, this funding model wasn’t just encouraged—it became the backbone of America’s infrastructure strategy. Whether that’s a genius move or a logistical […]
Pfizer’s 2025 Financial Outlook: A Corporate Powerhouse or a Market Mirage?
The Tightrope Between Profit and Public Good Pfizer has long been a major player in the pharmaceutical industry, leveraging both innovation and strategic partnerships to maintain its market position. Pfizer is a behemoth. No question about it. The pharmaceutical titan, famous (or infamous, depending on who you ask) for its COVID-19 treatments just dropped its 2025 […]
General Dynamics’ Financial Surge: A Triumph or Just Smoke and Mirrors?
Booming Revenues, But What’s the Catch? Money’s pouring in—$13.3 billion in Q4 2024 alone, a staggering 14.3% increase. That’s not just “solid growth”; that’s a flex. Yet, the stock market? Unimpressed. Analysts, those fickle gatekeepers of financial sentiment, are playing it cautious. Jefferies even slashed General Dynamics’ stock target to $270, murmuring about (big shock) […]
Revolutionizing Federal Spending: 5 Bold Benefits of Federal Procurement Reform GSA Centralization
In a world where every tax dollar counts, the U.S. Federal Government is turning the tide on how it does business. The new executive order on federal procurement reform GSA centralization, signed by President Donald J. Trump, is no mere administrative tweak. It’s a bold, sweeping move to reclaim efficiency, restore purpose, and reshape how Uncle […]